Distribución anormal de la grasa corporal y tipo de tratamiento antirretroviral como predictores de riesgo de enfermedad cardiovascular en pacientes infectados por el virus de la inmunodeficiencia humanaAbnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients
Referencias Bibliográficas (22)
- et al.
Protease inhibitors and cardiovascular outcomes in patients with HIV-1
Lancet
(2002) - et al.
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study
Lancet
(2001) - et al.
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study
Lancet
(1999) - et al.
Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction
Circulation
(2001) - et al.
Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study
Arch Intern Med
(2000) - et al.
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection
N Engl J Med
(2003) - et al.
Alteraciones del metabolismo de los lípidos en los pacientes infectados por el virus de la inmunodeficiencia humana. Una hipótesis acerca de su patogenia
Med Clin (Barc)
(2000) - et al.
Clinical assessment of HIV-associated lipodystrophy in an ambulatory population
AIDS
(2001) The sixth report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Arch Intern Med
(1997)Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Diabetes Care
(2002)
Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretrovírico en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2000 (I)
Enferm Infecc Microbiol Clin
(2000)
Cited by (12)
Variability in coronary risk assessment in HIV-infected patients
2007, Medicina ClinicaCoronary heart disease risks and lifestyle behaviors in persons with HIV infection
2006, Journal of the Association of Nurses in AIDS CareCardiovascular risk and HIV-infection in prison inmates [1]
2005, Medicina ClinicaAn inhibitor of HIV-1 protease modulates constitutive eIF2α dephosphorylation to trigger a specific integrated stress response
2016, Proceedings of the National Academy of Sciences of the United States of AmericaSequence-specific alterations of epitope production by HIV protease inhibitors
2014, Journal of ImmunologyThe metabolic syndrome and HIV infection
2014, Current Pharmaceutical Design
Copyright © 2004 Elsevier España, S.L. All rights reserved.